![Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-13560-z/MediaObjects/41598_2022_13560_Fig2_HTML.png)
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports
![Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-13560-z/MediaObjects/41598_2022_13560_Fig4_HTML.png)
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports
![Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-13560-z/MediaObjects/41598_2022_13560_Fig3_HTML.png)
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports
![Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-13560-z/MediaObjects/41598_2022_13560_Fig1_HTML.png)
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease | Scientific Reports
![DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.9b00093/asset/images/large/ml-2019-00093k_0006.jpeg)
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters
![Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? | Journal of Medicinal Chemistry Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.5b01009/asset/images/large/jm-2015-01009s_0003.jpeg)
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? | Journal of Medicinal Chemistry
Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during t
![Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19 Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19](https://www.frontiersin.org/files/Articles/899617/fimmu-13-899617-HTML-r1/image_m/fimmu-13-899617-g002.jpg)
Frontiers | Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19
![Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response](https://www.frontiersin.org/files/Articles/828734/fimmu-13-828734-HTML-r1/image_m/fimmu-13-828734-g001.jpg)
Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response
DOCTOR OF UNIVERSITÉ DE BORDEAUX AND UNIVERSIDAD PERUANA CAYETANO HEREDIA DEVELOPMENT OF A TEST ASSOCIATED WITH MAGNETIC NANO
![Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic | Revista de Gastroenterología de México Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic | Revista de Gastroenterología de México](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/thumbnail/S2255534X21001390:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w97o/wdEXW47bqlyT1CqG6R0=)
Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic | Revista de Gastroenterología de México
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? | Journal of Medicinal Chemistry
![Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response](https://www.frontiersin.org/files/Articles/828734/fimmu-13-828734-HTML-r1/image_m/fimmu-13-828734-g002.jpg)
Frontiers | Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response
![DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors | ACS Medicinal Chemistry Letters](https://pubs.acs.org/cms/10.1021/acsmedchemlett.9b00093/asset/images/large/ml-2019-00093k_0003.jpeg)